•
Dec 31, 2013

Ironwood Pharmaceuticals Q4 2013 Earnings Report

Total Revenue
$5.03M
Previous year: $27M
-81.4%
EPS
-$0.43
Previous year: -$0.41
+4.9%
Gross Profit
$4.5M
Previous year: $26M
-82.7%
Cash and Equivalents
$75.5M
Previous year: $137M
-44.8%
Free Cash Flow
-$45.8M
Previous year: -$25.8M
+77.2%
Total Assets
$279M
Previous year: $230M
+21.3%

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals